ResearcherGerman Cancer Research CenterActive in the last 2 years
Ergül Eyol
Matched on ORCID iD 0009-0000-3699-6725; OpenAlex author ID A5047458251. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- EPI-X4, a CXCR4 antagonist inhibits tumor growth in pancreatic cancer and lymphoma models. Co-author DOI 10.1016/j.peptides.2023.171111↗
- The CCR5 antagonist maraviroc causes remission of pancreatic cancer liver metastasis in nude rats based on cell cycle inhibition and apoptosis induction. Co-author DOI 10.1016/j.canlet.2020.01.009↗
- Few genes are associated with the capability of pancreatic ductal adenocarcinoma cells to grow in the liver of nude rats. Co-author DOI 10.3892/or.2012.2049↗
- Expression of HOXC8 is inversely related to the progression and metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/bjc.2011.217↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Martin Reinhold Berger · 4 shared papers, 2011–2024 · strength 0.38
- Paper EPI-X4, a CXCR4 antagonist inhibits tumor growth in pancreatic cancer and lymphoma models. DOI 10.1016/j.peptides.2023.171111↗
- Paper The CCR5 antagonist maraviroc causes remission of pancreatic cancer liver metastasis in nude rats based on cell cycle i… DOI 10.1016/j.canlet.2020.01.009↗
- Paper Few genes are associated with the capability of pancreatic ductal adenocarcinoma cells to grow in the liver of nude rat… DOI 10.3892/or.2012.2049↗
- Diana Behrens · 1 shared paper, 2024 · strength 0.20
- Wolf‐Georg Forssmann · 1 shared paper, 2024 · strength 0.20
- Doaa M. Ali · 1 shared paper, 2024 · strength 0.20
- Micah N. Sagini · 1 shared paper, 2024 · strength 0.20
- Huiying Huang · 1 shared paper, 2020 · strength 0.13
- Hassan Adwan · 2 shared papers, 2011–2012 · strength 0.06
- Jorg H. Kleeff · 2 shared papers, 2011–2012 · strength 0.06
- Helmut Frieß · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.